abeglutide glp-1 Agonists: Revolutionizing the Treatment of Obesity, but Are They Enough? - Eric Velazquez, MD - Bariatric Surgeon - Longstreet Clinic Center for Weight Management GLP-1 Medication for Weight Loss:

Trevis experimental therapy, Haduvio (nalbuphine ER), has shown significant reductions in 24-hour cough frequency during Phase 2 trials for refractory chronic cough (RIVER trial) and idiopathic pulmonary fibrosis-related cough (CORAL trial)

Three triple agonists are currently in clinical trials: retatrutide (Eli Lilly), HM15211 (Hanmi Pharmaceutical), and SAR441255 (Sanofi)

Understanding these distinctions can help you choose the best treatment option for your health goals

While this second study showed lower relative risk than the July study, both confirm an elevated risk

After injection, remove the needle immediately and dispose of it safely in a sharps container